Stay updated on Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Locations section now lists a large set of new site locations across the United States, Canada, the United Kingdom, Australia, India, and other regions, replacing the prior shorter listing with a more expansive directory. This broadens where the study is conducted and how potential participants can locate a site.
    Difference
    2%
    Check dated 2025-12-23T21:20:57.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Publications section now clarifies that PubMed entries are auto-filled and may not all pertain to the study. The page revision has been updated to v3.3.2, replacing the previous v3.2.0 text.
    Difference
    0.2%
    Check dated 2025-11-25T10:34:19.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Removed the government funding lapse banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T06:51:00.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The screenshots show the same study details page for NCT02792218 with identical sections (study overview, eligibility, locations, outcomes). No substantive changes to core content or data were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:40:35.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Adds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).
    Difference
    1%
    Check dated 2025-10-06T05:12:49.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.0%
    Check dated 2025-09-29T02:57:51.000Z thumbnail image

Stay in the know with updates to Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.